Puma Biotechnology Inc

-0.24 (-5.26%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)197.17M
Current PE20.05
Forward PE 25.41
2yr Forward PE 48
See more stats
Estimates Current Quarter
Revenue$57.06 Million
Adjusted EPS$0.05
See more estimates
10-Day MA$4.16
50-Day MA$2.82
200-Day MA$2.74
See more pivots

Puma Biotechnology Inc Stock, NASDAQ:PBYI

10880 Wilshire Boulevard, Suite 2150, Los Angeles, California 90024-4101
United States of America
Phone: +1.424.248.6500
Number of Employees: 196


Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.